About Dreavent Capital
Dreavent Capital is a Financial Services company based in Cambridge (United States). Biotech investments are managed by Dreavent Capital for innovation. It operates on a Commission-Based model in Financial Services and Healthcare sectors. Dreavent Capital offers products and services including Biotech Investments. Its focus areas include Finance, Investment Management, Venture Capital and Biotechnology.
Company details
Biotech investments are facilitated by Dreavent Capital, focusing on emerging U.S. biopharma companies. Support is provided to convert scientific research into patient treatments. Sectors such as Oncology, Neurology, Cardiovascular Metabolic, and Immunology are targeted. Strategic partnerships with global pharmaceutical companies and investment groups are maintained. Opportunities in life science research are pursued to develop new medical solutions. Collaboration with innovators is emphasized to address critical healthcare needs.
- Headquarters Cambridge, United States
- SectorsFinancial ServicesHealthcare
- Email••••••••
- Phone•••• ••••
- Website dreaventcapital.com
- Social LinkedIn
Products & Services of Dreavent Capital
Dreavent Capital offers a comprehensive portfolio of products and services, including Biotech Investments.
Investments in biotech firms are strategically managed here.
Top companies in Venture Capital Funds
3 companies that operate in the same segment as Dreavent Capital (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dreavent Capital
Dreavent Capital is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Biotech investments are facilitated by Dreavent Capital, focusing on emerging U.S. biopharma companies. Support is provided to convert scientific research into patient treatments. Sectors such as Oncology, Neurology, Cardiovascular Metabolic, and Immunology are targeted. Strategic partnerships with global pharmaceutical companies and investment groups are maintained. Opportunities in life science research are pursued to develop new medical solutions. Collaboration with innovators is emphasized to address critical healthcare needs.
Dreavent Capital offers Biotech Investments.